Krogsgaard Laura Rindom, Engsbro Anne Line, Bytzer Peter
a Department of Medicine , Zealand University Hospital , Køge , Denmark.
b Department of Clinical Microbiology , Hvidovre University Hospital , Hvidovre , Denmark.
Scand J Gastroenterol. 2018 Sep;53(9):1027-1030. doi: 10.1080/00365521.2018.1500638. Epub 2018 Sep 6.
Use of antibiotics affects the composition of the gut microbiome. The microbiome is thought to play a role in development of irritable bowel syndrome (IBS), but antibiotics as a possible risk factor for IBS has not been clarified. We aimed to explore if antibiotics is a risk factor for IBS by investigating use of antibiotics and development of IBS in a cohort from the Danish background population.
An internet-based web panel representative of the Danish background population was invited to participate in a survey regarding the epidemiology of IBS in 2010, 2011 and 2013. A questionnaire based on the Rome III criteria for IBS were answered at all three occasions. In 2013, a question regarding use of antibiotics in the past year was included.
In 2013, use of antibiotics was reported by 22.4% (624/2781) of the population. A higher proportion of individuals with IBS reported use of antibiotics compared with asymptomatic controls [29.0% (155/534) vs. 17.9% (212/1,184), p < .01]. For asymptomatic respondents in 2010 and 2011 (n = 1004), the relative risk of IBS in 2013 related with use of antibiotics was 1.9 [95% confidence interval (CI): 1.1-3.1]. Adjusting for sex by logistic regression, development of IBS was predicted by use of antibiotics with an odds ratio of 1.8 (95% CI: 1.0-3.2).
Antibiotics is a risk factor for IBS in asymptomatic individuals. Possible mechanisms should be investigated in future studies.
抗生素的使用会影响肠道微生物群的组成。人们认为微生物群在肠易激综合征(IBS)的发展中起作用,但抗生素作为IBS的一个可能风险因素尚未明确。我们旨在通过调查丹麦背景人群队列中抗生素的使用情况和IBS的发生情况,探讨抗生素是否为IBS的风险因素。
邀请一个代表丹麦背景人群的基于互联网的网络小组参与2010年、2011年和2013年关于IBS流行病学的调查。在所有这三次调查中,都要回答一份基于罗马III IBS标准的问卷。2013年,增加了一个关于过去一年抗生素使用情况的问题。
2013年,22.4%(624/2781)的人群报告使用了抗生素。与无症状对照组相比,IBS患者中报告使用抗生素的比例更高[29.0%(155/534)对17.9%(212/1184),p<0.01]。对于2010年和2011年无症状的受访者(n = 1004),2013年与使用抗生素相关的IBS相对风险为1.9[95%置信区间(CI):1.1 - 3.1]。通过逻辑回归调整性别后,使用抗生素预测IBS发生的比值比为1.8(95%CI:1.0 - 3.2)。
抗生素是无症状个体发生IBS的一个风险因素。未来的研究应调查可能的机制。